Category: Bristol-Myers shares slump after failed AstraZeneca drug trial

Bristol-Myers shares slump after failed AstraZeneca drug trial

  1. Bristol-Myers shares slump after failed AstraZeneca drug trial  Reuters
  2. Did the Checkpoint Inhibitor Bubble Just Burst?  Motley Fool
  3. Bristol-Myers (BMY) Beats on Q2 Earnings, Tweaks 2017 View  Nasdaq
  4. Full coverage

from Business – Google News http://www.reuters.com/article/us-bristolmyers-results-idUSKBN1AC1MU

Advertisements